Henriksen J H, Bentsen K D, Laurent T C
Department of Clinical Physiology, Hvidovre Hospital, University of Copenhagen, Denmark.
J Hepatol. 1988 Apr;6(2):158-66. doi: 10.1016/s0168-8278(88)80027-8.
Splanchnic and renal extraction of hyaluronan was determined in patients with alcoholic cirrhosis (n = 9), non-cirrhotic alcoholic liver disease (n = 5), and controls without liver disease (n = 19) in the supine fasting condition. Arterial plasma concentration of hyaluronan was significantly increased in patients with cirrhosis (mean 480 micrograms/l) as compared to non-cirrhotic patients (29 micrograms/l, P less than 0.001) and controls (25 micrograms/l, P less than 0.001), whereas no difference was present between the two last-mentioned groups. In patients with liver disease, circulating hyaluronan was inversely correlated to indocyanine green clearance (r = -0.85, P less than 0.001) and to galactose elimination capacity (r = -0.62, P less than 0.02), but positively correlated to portal pressure (determined as wedged-to-free hepatic vein pressure) (r = 0.92, P less than 0.001). Splanchnic extraction ratio (arterio-hepatic venous extraction ratio) had a mean value of 0.14 in patients with cirrhosis as compared to 0.36 in non-cirrhotic patients (P less than 0.05) and 0.34 in controls (P less than 0.025). Splanchnic hyaluronan extraction was not correlated to liver function tests or portal pressure. In patients with alcoholic liver disease no significant renal hyaluronan extraction was found as compared to an extraction ratio of 0.17 in controls (P less than 0.05). Our results suggest that the increased level of circulating endogenous hyaluronan found in patients with cirrhosis is caused by a combination of increased supply to and decreased extraction from plasma.
在空腹仰卧状态下,对酒精性肝硬化患者(n = 9)、非肝硬化酒精性肝病患者(n = 5)和无肝病的对照组(n = 19)进行了透明质酸的内脏和肾脏摄取测定。与非肝硬化患者(29微克/升,P < 0.001)和对照组(25微克/升,P < 0.001)相比,肝硬化患者的动脉血浆透明质酸浓度显著升高(平均480微克/升),而后两组之间无差异。在肝病患者中,循环透明质酸与吲哚菁绿清除率呈负相关(r = -0.85,P < 0.001),与半乳糖清除能力呈负相关(r = -0.62,P < 0.02),但与门静脉压力(通过楔压与游离肝静脉压力测定)呈正相关(r = 0.92,P < 0.001)。肝硬化患者的内脏摄取率(动脉 - 肝静脉摄取率)平均值为0.14,而非肝硬化患者为0.36(P < 0.05),对照组为0.34(P < 0.025)。内脏透明质酸摄取与肝功能试验或门静脉压力无关。与对照组0.17的摄取率相比,酒精性肝病患者未发现明显的肾脏透明质酸摄取(P < 0.05)。我们的结果表明,肝硬化患者循环内源性透明质酸水平升高是血浆供应增加和摄取减少共同作用的结果。